<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:10:17Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9890214" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9890214</identifier>
        <datestamp>2023-02-02</datestamp>
        <setSpec>jac</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Antimicrob Chemother</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Antimicrob Chemother</journal-id>
              <journal-id journal-id-type="publisher-id">jac</journal-id>
              <journal-title-group>
                <journal-title>Journal of Antimicrobial Chemotherapy</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0305-7453</issn>
              <issn pub-type="epub">1460-2091</issn>
              <publisher>
                <publisher-name>Oxford University Press</publisher-name>
                <publisher-loc>US</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9890214</article-id>
              <article-id pub-id-type="pmcid">PMC9890214</article-id>
              <article-id pub-id-type="pmc-uid">9890214</article-id>
              <article-id pub-id-type="pmid">36480295</article-id>
              <article-id pub-id-type="pmid">36480295</article-id>
              <article-id pub-id-type="doi">10.1093/jac/dkac398</article-id>
              <article-id pub-id-type="publisher-id">dkac398</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Original Research</subject>
                </subj-group>
                <subj-group subj-group-type="category-taxonomy-collection">
                  <subject>AcademicSubjects/MED00740</subject>
                  <subject>AcademicSubjects/MED00290</subject>
                  <subject>AcademicSubjects/MED00230</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Exploring the <italic toggle="yes">in situ</italic> evolution of nitrofurantoin resistance in clinically derived uropathogenic <italic toggle="yes">Escherichia coli</italic> isolates</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Vallée</surname>
                    <given-names>Maxime</given-names>
                  </name>
                  <aff><institution>Biosciences Institute, Faculty of Medical Sciences, Newcastle University</institution>, <country country="GB">UK</country></aff>
                  <aff><institution>Department of Urology, Poitiers University Hospital</institution>, <addr-line>2 Rue de la Milétrie, 86021 Poitiers</addr-line>, <country country="FR">France</country></aff>
                  <xref rid="dkac398-FM1" ref-type="author-notes"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Harding</surname>
                    <given-names>Chris</given-names>
                  </name>
                  <aff><institution>Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University</institution>, <country country="GB">UK</country></aff>
                  <aff><institution>Urology Department, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust</institution>, <country country="GB">UK</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hall</surname>
                    <given-names>Judith</given-names>
                  </name>
                  <aff><institution>Biosciences Institute, Faculty of Medical Sciences, Newcastle University</institution>, <country country="GB">UK</country></aff>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6488-7593</contrib-id>
                  <name>
                    <surname>Aldridge</surname>
                    <given-names>Phillip D</given-names>
                  </name>
                  <aff><institution>Biosciences Institute, Faculty of Medical Sciences, Newcastle University</institution>, <country country="GB">UK</country></aff>
                  <xref rid="dkac398-cor1" ref-type="corresp"/>
                  <!--phillip.aldridge@ncl.ac.uk-->
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>TAN</surname>
                    <given-names>Aaron</given-names>
                  </name>
                  <aff><institution>Biosciences Institute, Faculty of Medical Sciences, Newcastle University</institution>, <country country="GB">UK</country></aff>
                  <xref rid="dkac398-FM1" ref-type="author-notes"/>
                  <xref rid="dkac398-cor2" ref-type="corresp"/>
                </contrib>
              </contrib-group>
              <author-notes>
                <corresp id="dkac398-cor1">Corresponding author. E-mail: <email>phillip.aldridge@ncl.ac.uk</email></corresp>
                <fn id="dkac398-FM1">
                  <p>Maxime Vallée and Aaron TAN contributed equally to this work.</p>
                </fn>
                <corresp id="dkac398-cor2">Current address: SCELSE, Nanyang Technological University, SBS-01N-27, 60 Nanyang Drive, 637551, Singapore.</corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <month>2</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="epub" iso-8601-date="2022-12-08">
                <day>08</day>
                <month>12</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>08</day>
                <month>12</month>
                <year>2022</year>
              </pub-date>
              <volume>78</volume>
              <issue>2</issue>
              <fpage>373</fpage>
              <lpage>379</lpage>
              <history>
                <date date-type="received">
                  <day>19</day>
                  <month>7</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>30</day>
                  <month>10</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
                  <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
                </license>
              </permissions>
              <self-uri xlink:href="dkac398.pdf"/>
              <abstract>
                <title>Abstract</title>
                <sec id="s1">
                  <title>Background</title>
                  <p>Nitrofurantoin has been re-introduced as a first-choice antibiotic to treat uncomplicated acute urinary tract infections in England and Wales. Highly effective against common uropathogens such as <italic toggle="yes">Escherichia coli</italic>, its use is accompanied by a low incidence (&lt;10%) of antimicrobial resistance. Resistance to nitrofurantoin is predominantly via the acquisition of loss-of-function, step-wise mutations in the nitroreductase genes <italic toggle="yes">nfsA</italic> and <italic toggle="yes">nfsB</italic>.</p>
                </sec>
                <sec id="s2">
                  <title>Objective</title>
                  <p>To explore the <italic toggle="yes">in situ</italic> evolution of Nit<sup>R</sup> in <italic toggle="yes">E. coli</italic> isolates from 17 patients participating in AnTIC, a 12-month open label randomized controlled trial assessing the efficacy of antibiotic prophylaxis in reducing urinary tract infections (UTIs) incidence in clean intermittent self-catheterizing patients.</p>
                </sec>
                <sec id="s3">
                  <title>Methods</title>
                  <p>The investigation of Nit<sup>R</sup> evolution in <italic toggle="yes">E. coli</italic> used general microbiology techniques and genetics to model known Nit<sup>R</sup> mutations in Nit<sup>S</sup><italic toggle="yes">E. coli</italic> strains.</p>
                </sec>
                <sec id="s4">
                  <title>Results</title>
                  <p>Growth rate analysis identified a 2%–10% slower doubling time for nitrofurantoin resistant strains: Nit<sup>S</sup>: 20.8 ± 0.7 min compared to Nit<sup>R</sup>: 23 ± 0.8 min. Statistically, these data indicated no fitness advantage of evolved strains compared to the sensitive predecessor (<italic toggle="yes">P</italic>-value = 0.13). Genetic manipulation of <italic toggle="yes">E. coli</italic> to mimic Nit<sup>R</sup> evolution, supported no fitness advantage (<italic toggle="yes">P</italic>-value = 0.22). In contrast, data argued that a first-step mutant gained a selective advantage, at sub-MIC (4–8 mg/L) nitrofurantoin concentrations.</p>
                </sec>
                <sec id="s5">
                  <title>Conclusion</title>
                  <p>Correlation of these findings to nitrofurantoin pharmacokinetic data suggests that the low incidence of <italic toggle="yes">E. coli</italic> Nit<sup>R</sup>, within the community, is driven by urine-based nitrofurantoin concentrations that selectively inhibit the growth of <italic toggle="yes">E. coli</italic> strains carrying the key first-step loss-of-function mutation.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>NIHR HTA</institution>
                      <institution-id institution-id-type="doi">10.13039/501100000664</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>11/72/01</award-id>
                </award-group>
              </funding-group>
              <counts>
                <page-count count="7"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="dkac398-s0">
              <title>Introduction</title>
              <p>Nitrofurantoin is a broad-spectrum antibiotic that has been used since the mid-1950s to manage uncomplicated urinary tract infections (UTIs).<sup><xref rid="dkac398-B1" ref-type="bibr">1</xref></sup> With the introduction of trimethoprim and modern β-lactam antibiotics its popularity waned in the 1970s.<sup><xref rid="dkac398-B1" ref-type="bibr">1</xref>,<xref rid="dkac398-B2" ref-type="bibr">2</xref></sup> However, due to increased antimicrobial resistance the 2015 England and Wales NICE recommendations replaced trimethoprim with nitrofurantoin as the front-line antibiotic treatment for uncomplicated lower UTIs. <sup><xref rid="dkac398-B3" ref-type="bibr">3</xref></sup> Reassuringly, increases in nitrofurantoin prescriptions have not only been associated with decreased trimethoprim resistance, but also with no apparent changes in nitrofurantoin resistance, consistently, below 10%. <sup><xref rid="dkac398-B4" ref-type="bibr">4</xref></sup></p>
              <p>Nitrofurantoin is effective against a variety of common uropathogenic bacterial species, including <italic toggle="yes">E. coli</italic>, <italic toggle="yes">Enterococcus</italic> spp., <italic toggle="yes">Enterobacter</italic> spp. and <italic toggle="yes">Klebsiella</italic> spp.<sup><xref rid="dkac398-B5" ref-type="bibr">5</xref>,<xref rid="dkac398-B6" ref-type="bibr">6</xref></sup> It has been established that many of these uropathogens carry genes encoding oxygen insensitive nitroreductases, which convert nitrofurantoin into electrophilic intermediates that attack bacterial ribosomal proteins, thereby inhibiting protein synthesis and facilitating microbial death.<sup><xref rid="dkac398-B5" ref-type="bibr">5</xref></sup> When nitrofurantoin is present at high concentrations, these intermediates can also interfere in nucleic acid synthesis and aerobic metabolism targeting the citric acid cycle.<sup><xref rid="dkac398-B5" ref-type="bibr">5</xref></sup> Bacterial nitroreductases are not essential proteins, allowing for the acquisition of chromosomally derived loss-of-function mutations generating nitrofurantoin resistance (Nit<sup>R</sup>).<sup><xref rid="dkac398-B7" ref-type="bibr">7</xref></sup> In <italic toggle="yes">E. coli</italic>, the inactivation, via deletion or point mutation, of the genes <italic toggle="yes">nfsA</italic> and <italic toggle="yes">nfsB</italic>, is the common route to Nit<sup>R</sup>.<sup><xref rid="dkac398-B7" ref-type="bibr">7</xref></sup> Other pathways leading to Nit<sup>R</sup> include the horizonal acquisition of the efflux system <italic toggle="yes">oqxAB</italic> or chromosomal mutations in <italic toggle="yes">ribE.</italic><sup><xref rid="dkac398-B8" ref-type="bibr">8</xref></sup></p>
              <p>Inactivation of <italic toggle="yes">nfsA</italic> and <italic toggle="yes">nfsB</italic> follows a two-step evolutionary pathway: <italic toggle="yes">nfsA</italic> before <italic toggle="yes">nfsB.</italic><sup><xref rid="dkac398-B9" ref-type="bibr">9</xref></sup> Supporting this evolutionary pathway, genetic surveillance studies of Nit<sup>R</sup> uncovered <italic toggle="yes">nfsA<sup>−</sup> nfsB<sup>+</sup></italic> isolates, but seldom the reciprocal <italic toggle="yes">nfsA<sup>+</sup> nfsB<sup>−</sup></italic> combination.<sup><xref rid="dkac398-B8" ref-type="bibr">8</xref>,<xref rid="dkac398-B10" ref-type="bibr">10</xref></sup> Sandegren <italic toggle="yes">et al.</italic> provided insight into potential factors contributing to the low incidence of Nit<sup>R</sup> among <italic toggle="yes">E. coli</italic> isolates suggesting the growth rate of Nit<sup>R</sup> isolates to be 3%–6% slower compared to Nit<sup>S</sup> isolates.<sup><xref rid="dkac398-B11" ref-type="bibr">11</xref></sup> These authors concluded there was a fitness cost to uro-associated <italic toggle="yes">E. coli</italic> of inactivating <italic toggle="yes">nfsA/nfsB.</italic><sup><xref rid="dkac398-B11" ref-type="bibr">11</xref></sup> This loss of fitness may impact the establishment of resistant isolates in the urinary tract, explaining the low incidence of nitrofurantoin resistance among urinary <italic toggle="yes">E. coli</italic> isolates.<sup><xref rid="dkac398-B11" ref-type="bibr">11</xref></sup></p>
              <p>While genome surveillance studies support Nit<sup>R</sup> being linked to point mutations and deletions of the <italic toggle="yes">nfsA/nfsB</italic> genes,<sup><xref rid="dkac398-B8" ref-type="bibr">8</xref>,<xref rid="dkac398-B10" ref-type="bibr">10</xref></sup> they are unable to explain the factors that drive resistance phenotype selection. Understanding these factors is key to informing prescribing guidelines that underpin UTI treatments and future urology antibiotic stewardship programmes. AnTIC was an open label randomized controlled trial that assessed the efficacy of antibiotic prophylaxis in reducing the incidence of symptomatic UTIs in clean intermittent self-catheterized patients over a period of 12 months.<sup><xref rid="dkac398-B12" ref-type="bibr">12</xref></sup> Forty-five isolates from 17 patients experiencing persistent uro-associated <italic toggle="yes">E. coli</italic> colonization were analysed by WGS <sup><xref rid="dkac398-B13" ref-type="bibr">13</xref></sup> and five isolates from two patients (PAT1646 and PAT2015) supported Nit<sup>R</sup> acquisition during the trial period. Clinical data associated with these cases confirmed exposure to nitrofurantoin. One case provided an opportunity to investigate the <italic toggle="yes">in situ</italic> evolutionary dynamics driving nitrofurantoin resistance and address aspects of the Nit<sup>R</sup> phenotype that underpin the low incidence of Nit<sup>R</sup> observed among community isolates of <italic toggle="yes">E. coli</italic>.</p>
            </sec>
            <sec sec-type="methods" id="dkac398-s1">
              <title>Materials and methods</title>
              <sec id="dkac398-s1.1">
                <title>Bacterial strains</title>
                <p>Strains used or constructed in this study are shown in the Supplementary materials (Table <xref rid="sup1" ref-type="supplementary-material">S1</xref>, available as Supplementary data at <italic toggle="yes">JAC</italic> Online). Antibiotics for selection were used at concentrations described previously.<sup><xref rid="dkac398-B14" ref-type="bibr">14</xref></sup></p>
              </sec>
              <sec id="dkac398-s1.2">
                <title>pBKK plasmid construction</title>
                <p>Five pBKK plasmids carrying different DNA constructs of the <italic toggle="yes">nfsA</italic> or <italic toggle="yes">nfsB</italic> region (<italic toggle="yes">nfsA</italic> 1646B, Δ<italic toggle="yes">nfsA</italic>, Δ<italic toggle="yes">nfsA-rimK</italic>, Δ<italic toggle="yes">rimK</italic> and Δ<italic toggle="yes">nfsB</italic>) were generated using Gibson assembly, with pBKK as the vector backbone. The pBKK vector was constructed using Gibson assembly, with pBlueScript II SK (Ampicillin resistant) as the vector backbone and the kanamycin resistance gene from pKD4 as the insert. All plasmids were sequenced and primers are defined in Table <xref rid="sup1" ref-type="supplementary-material">S2</xref>.</p>
              </sec>
              <sec id="dkac398-s1.3">
                <title>Mutant generation</title>
                <p><italic toggle="yes">nfsA/nfsB</italic> mutants were generated using a two-step recombination strategy involving the lambda-red and CRISPR systems.<sup><xref rid="dkac398-B15" ref-type="bibr">15</xref>,<xref rid="dkac398-B16" ref-type="bibr">16</xref></sup> The mutagenesis protocol has been previously described.<sup><xref rid="dkac398-B17" ref-type="bibr">17</xref></sup> During CRISPR mutagenesis, <italic toggle="yes">cat</italic> was replaced with a DNA construct carrying a modified version of the <italic toggle="yes">nfsA/nfsB</italic> region (Δ<italic toggle="yes">nfsA</italic>, Δ<italic toggle="yes">nfsA-rimK</italic>, Δ<italic toggle="yes">rimK</italic>, <italic toggle="yes">nfsA</italic> T37M, Δ<italic toggle="yes">nfsB</italic>, Δ<italic toggle="yes">nfsB30</italic>). Where necessary the target mutant was amplified from the pBKK plasmids or directly from chromosomal DNA (<italic toggle="yes">nfsA</italic> T37M and Δ<italic toggle="yes">nfsB30</italic>). Double mutants were generated by first replacing the <italic toggle="yes">nfsA</italic> region with the appropriate DNA construct followed by the <italic toggle="yes">nfsB</italic> region. Confirmation of mutants was conducted through colony PCR and sequencing.</p>
              </sec>
              <sec id="dkac398-s1.4">
                <title>MIC and growth assay and analysis</title>
                <p>Using standard microbiology protocols MIC and growth curve assays were performed using sterile Greiner Bio-One clear 96-well flat-bottom plates. Technical details are reported in the Supplementary material. For MIC assays, no-growth was defined as an average optical density (OD<sub>600</sub>) reading over three independent repeats as &lt;0.05. If an OD<sub>600</sub> &gt;0.05 was identified, the MIC was taken as the next upper concentration. The maximum doubling time of each isolate was derived from the maximum slope calculated using a moving ‘frame’ of eight timepoints using basic R coding.<sup><xref rid="dkac398-B18" ref-type="bibr">18</xref></sup> Statistical analysis of the doubling times was performed using either <italic toggle="yes">t</italic>-tests or ANOVA. For <italic toggle="yes">t</italic>-tests, the Bonferroni correction was considered to determine the threshold <italic toggle="yes">P</italic>-value for significance.</p>
              </sec>
              <sec id="dkac398-s1.5">
                <title>Viability and competition assays</title>
                <p>Overnight bacterial cultures were diluted to achieve a starting density of 50–100 cfu/mL in 6 mL of MHB media and incubated for 16 hours at 37°C. Cultures were plated onto CPSE plates, incubated overnight at 37°C, photographed and colonies counted with the image processing package ImageJ. Competition assays were performed using the same protocol with adjusted volumes to incorporate the addition of two strains. Visual differentiation between strains was achieved by deleting <italic toggle="yes">uidA</italic>, the β-glucuronidase that leads to <italic toggle="yes">E. coli</italic> being red on CPSE plates. The competitive index was defined as log<sub>10</sub>(strain A cfu/mL: strain B cfu/mL).</p>
              </sec>
              <sec id="dkac398-s1.6">
                <title>Ethical approval</title>
                <p>Permission to use clinical isolates and data from the AnTIC clinical study was derived from prior ethical approvals (ethics 19/NS/0024, IRAS Project ID 243903, Ref. 2586/2016).<sup><xref rid="dkac398-B13" ref-type="bibr">13</xref></sup></p>
              </sec>
            </sec>
            <sec sec-type="results" id="dkac398-s2">
              <title>Results</title>
              <sec id="dkac398-s2.1">
                <title>In situ development of nitrofurantoin resistance amongst clinical E. coli isolates</title>
                <p>Forty-five (45) uro-associated isolates from 17 AnTIC patients with persistent <italic toggle="yes">E. coli</italic> colonization were previously analysed using WGS.<sup><xref rid="dkac398-B13" ref-type="bibr">13</xref></sup> Five isolates from two patients (PAT1646 and PAT2015) provided examples that supported <italic toggle="yes">in situ E. coli</italic> acquisition of nitrofurantoin resistance following exposure to the antibiotic. MLST and cgMLST genotyping confirmed stable <italic toggle="yes">E. coli</italic> colonization in both patients (Figure <xref rid="dkac398-F1" ref-type="fig">1a</xref>). PAT1646 was colonized by ST131, whereas PAT2015 was colonized by ST58 (Figure <xref rid="sup1" ref-type="supplementary-material">S1</xref>). The Nit<sup>S</sup> (MIC 8 mg/L) baseline isolate of PAT1646, 1646 BASE, possessed wild-type <italic toggle="yes">nfsA</italic> and <italic toggle="yes">nfsB</italic> genes (Figure <xref rid="dkac398-F1" ref-type="fig">1b</xref>). The 6-month isolate, 1646 6, was Nit<sup>R</sup> (MIC 128 mg/L: Figure <xref rid="dkac398-F1" ref-type="fig">1a</xref>) and had a T37M point mutation in <italic toggle="yes">nfsA</italic> and a complete deletion of <italic toggle="yes">nfsB</italic>, spanning 30 kb upstream of the start codon. The baseline isolate of PAT2015, 2015 BASE, was Nit<sup>S</sup> (MIC 32 mg/L) and carried a complete deletion of <italic toggle="yes">nfsA</italic>, but an intact, wild-type <italic toggle="yes">nfsB</italic> (Figure <xref rid="dkac398-F1" ref-type="fig">1b</xref>). The 12-month isolate, 2015 12, was Nit<sup>R</sup> (MIC 128 mg/L) having gained a partial deletion in <italic toggle="yes">nfsB</italic> (Figure <xref rid="dkac398-F1" ref-type="fig">1b</xref>).</p>
                <fig position="float" id="dkac398-F1" fig-type="figure">
                  <label>Figure 1.</label>
                  <caption>
                    <p>Acquisition of the Nit<sup>R</sup> phenotype in PAT1646 and PAT2015. (a) Timeline for each patient indicating the temporal isolation of each strain, the sequence type identified via MLST genotyping and the MIC for each isolate. (b) <italic toggle="yes">nfsA</italic> and <italic toggle="yes">nfsB</italic> genotype for the BASE and Nit<sup>R</sup> isolates from PAT1646 and PAT2015.</p>
                  </caption>
                  <graphic xlink:href="dkac398f1" position="float"/>
                </fig>
                <p>Growth kinetics of the BASE strains, and isolates 1646 6 and 2015 12, resulted in comparable growth curves (Figure <xref rid="dkac398-F2" ref-type="fig">2</xref>), which suggested no difference in bacterial fitness. Calculation of the doubling time were comparable for all four strains: 1646 BASE: 20.8 ± 0.7 min; 1646 6 23 ± 0.8 min; 2015 BASE: 21.0 ± 0.7 and 2015 12: 21.4 ± 0.7 (ANOVA <italic toggle="yes">P</italic>-value = 0.13). In the absence of antibiotic, competition between 1646 BASE and 1646 6 was minimal, reflected by a calculated competitive index of 0.22 ± 0.16. These data therefore argued against a fitness advantage playing a significant role in driving the acquisition of Nit<sup>R</sup> in UTI patients treated with nitrofurantoin.</p>
                <fig position="float" id="dkac398-F2" fig-type="figure">
                  <label>Figure 2.</label>
                  <caption>
                    <p>Growth characteristics of the BASE and Nit<sup>R</sup> isolates from PAT1646 and PAT2015. The differences between the doubling times are consistent with previous studies of Nit<sup>R</sup> but are not statistically significant (ANOVA <italic toggle="yes">P</italic> = 0.22). All data was calculated from <italic toggle="yes">n</italic> = 24 independent repeats of growth of each strain.</p>
                  </caption>
                  <graphic xlink:href="dkac398f2" position="float"/>
                </fig>
              </sec>
              <sec id="dkac398-s2.2">
                <title>Generating nfsA and nfsB mutants from Nit<sup>S</sup> isolates</title>
                <p>PAT1646 <italic toggle="yes">E. coli</italic> isolates represent a chronological ‘snapshot’ of the same strain before and after developing nitrofurantoin resistance (Figure <xref rid="dkac398-F1" ref-type="fig">1</xref>). To investigate the underlying advantage/disadvantage of acquiring the Nit<sup>R</sup> phenotype, mutants in <italic toggle="yes">nfsA</italic> and/or <italic toggle="yes">nfsB</italic>, were generated in 1646 BASE and the Nit<sup>S</sup> laboratory <italic toggle="yes">E. coli</italic> strain W3110, a commonly used ‘wild-type’ model strain (Figure <xref rid="sup1" ref-type="supplementary-material">S2</xref>).<sup><xref rid="dkac398-B19" ref-type="bibr">19</xref></sup> Comparing two isolates of contrasting genetic backgrounds (clinical versus laboratory), provided an opportunity to identify phenotypic effects, if any, of Δ<italic toggle="yes">nfsA/ΔnfsB</italic> combinations that were dependent or independent of genetic background. Mutants were generated by targeted mutagenesis rather than <italic toggle="yes">in vitro</italic> selection to minimize the acquisition of spontaneous, compensatory mutations linked to nitrofurantoin exposure, which could distort the phenotypic behaviour of Δ<italic toggle="yes">nfsA</italic>/Δ<italic toggle="yes">nfsB</italic> mutations.</p>
                <p><italic toggle="yes">rimK</italic> is in an operon with <italic toggle="yes">nfsA</italic> (Figure <xref rid="dkac398-F1" ref-type="fig">1b</xref>) and encodes an enzyme involved in the post-translational modification of ribosomal protein S6 via the addition of glutamate residues.<sup><xref rid="dkac398-B20" ref-type="bibr">20</xref></sup> There is evidence of clinical Nit<sup>R</sup> isolates carrying partial deletions in <italic toggle="yes">rimK</italic>, therefore Δ<italic toggle="yes">rimK</italic> and Δ<italic toggle="yes">nfsA-rimK</italic> mutations were also created (Figure <xref rid="sup1" ref-type="supplementary-material">S2</xref>).<sup><xref rid="dkac398-B13" ref-type="bibr">13</xref></sup> The flexibility of CRISPR–Cas technology allowed 1646 BASE to be engineered to model the impacts of the 1646 6 <italic toggle="yes">nfsA</italic> mutation (<italic toggle="yes">nfsA</italic> T37M) and the 30 kb <italic toggle="yes">nfsB</italic> deletion (Δ<italic toggle="yes">nfsB30</italic>). However, only <italic toggle="yes">nfsA</italic> T37M was modelled in W3110 (Figure <xref rid="sup1" ref-type="supplementary-material">S2</xref>).</p>
              </sec>
              <sec id="dkac398-s2.3">
                <title>Characterization of ΔnfsA/ΔnfsB mutants</title>
                <p>The Nit<sup>R</sup> phenotypes of the strains generated were quantitatively assessed via MIC assays (Figure <xref rid="dkac398-F3" ref-type="fig">3</xref>). Isolates with a MIC ≥ 64 mg/L were classified as Nit<sup>R</sup><sup><xref rid="dkac398-B21" ref-type="bibr">21</xref>,<xref rid="dkac398-B22" ref-type="bibr">22</xref></sup> and strains 1646 BASE, W3110 and 1646 6 were included as Nit<sup>S</sup> and Nit<sup>R</sup> controls. Single 1646B mutants with Δ<italic toggle="yes">nfsA</italic> or <italic toggle="yes">nfsA</italic> T37M supported MIC values of 32 mg/L thus still clinically Nit<sup>S</sup> (Figure <xref rid="dkac398-F3" ref-type="fig">3</xref>). Single mutants Δ<italic toggle="yes">rimK</italic>, Δ<italic toggle="yes">nfsB</italic> and Δ<italic toggle="yes">nfsB30</italic> showed a MIC comparable to their parental background. A similar pattern was observed for the W3110 although the Nit<sup>S</sup> MIC of the parent and <italic toggle="yes">nfsA</italic><sup>+</sup> variants was 8 mg/L (Figure <xref rid="dkac398-F3" ref-type="fig">3</xref>).</p>
                <fig position="float" id="dkac398-F3" fig-type="figure">
                  <label>Figure 3.</label>
                  <caption>
                    <p>MIC of Δ<italic toggle="yes">nfsA</italic> and Δ<italic toggle="yes">nfsB</italic> mutant combinations in 1646 BASE (filled bars) and the laboratory strain W3110 (open bars). The dashed horizontal line indicates the nitrofurantoin concentration defined as being the point at which strains are defined as clinically resistant to the antibiotic. Data represent a minimum of three independent repeats of the assay for each strain. MIC values represent the nitrofurantoin concentration where the average OD<sub>600</sub> reached &lt;0.05.</p>
                  </caption>
                  <graphic xlink:href="dkac398f3" position="float"/>
                </fig>
                <p><italic toggle="yes">In vitro</italic> 1646 6 and its corresponding engineered mutant (<italic toggle="yes">nfsA</italic> T37M Δ<italic toggle="yes">nfsB</italic>) showed MICs of ≥64 mg/L respectively. In contrast, 1646 BASE double mutants in which <italic toggle="yes">nfsA</italic> was inactivated via complete deletion (Δ<italic toggle="yes">nfsA</italic> Δ<italic toggle="yes">nfsB</italic>, Δ<italic toggle="yes">nfsA-rimK</italic> Δ<italic toggle="yes">nfsB</italic>) displayed higher MICs (128 mg/L) (Figure <xref rid="dkac398-F3" ref-type="fig">3</xref>). The MICs of the <italic toggle="yes">nfsA</italic><sup>+</sup> Δ<italic toggle="yes">rimK</italic> Δ<italic toggle="yes">nfsB</italic> variants were comparable to their single and parental derivatives (16 or 8 mg/L). Collectively, these data indicated that only single mutants with inactivated <italic toggle="yes">nfsA</italic> had a modest 2-fold MIC increase when compared to their parental isolate while double mutants, including Δ<italic toggle="yes">nfsA</italic>, had substantially higher MICs.</p>
              </sec>
              <sec id="dkac398-s2.4">
                <title>Plasmid-based complementation of Nit<sup>R</sup> ΔnfsA ΔnfsB mutants</title>
                <p>To verify that inactivating <italic toggle="yes">nfsA</italic> was critical in the acquisition of Nit<sup>R</sup>, the engineered 1646 BASE and W3110 Δ<italic toggle="yes">nfsA</italic> Δ<italic toggle="yes">nfsB</italic> mutants were transformed with modified pBlueScript II SK (pBKK) plasmids carrying genetic variants of the <italic toggle="yes">nfsA</italic> region (Figure <xref rid="dkac398-F4" ref-type="fig">4a</xref>). The pBKK empty vector was used as a negative control. MIC assays were performed on transformed strains (Figure <xref rid="dkac398-F4" ref-type="fig">4b</xref>). Complementation was only observed when pBKK plasmids carried functional <italic toggle="yes">nfsA</italic>. Consistent with the role that <italic toggle="yes">nfsA</italic> plays in the Nit<sup>R</sup> phenotype, complementation led to a strong 32-fold reduction in MIC compared to the negative control (Figure <xref rid="dkac398-F4" ref-type="fig">4b</xref>).</p>
                <fig position="float" id="dkac398-F4" fig-type="figure">
                  <label>Figure 4.</label>
                  <caption>
                    <p>Complementation of Δ<italic toggle="yes">nfsA</italic> with ectopic expression of <italic toggle="yes">nfsA</italic> from pBKK. (a) Schematic diagram of plasmid constructs used in these complementation assays. (b) MIC data for strains used. Data represent a minimum of three independent repeats of the assay for each strain. MIC values represent the nitrofurantoin concentration where the average OD<sub>600</sub> reached &lt;0.05.</p>
                  </caption>
                  <graphic xlink:href="dkac398f4" position="float"/>
                </fig>
              </sec>
              <sec id="dkac398-s2.5">
                <title>Fitness of nfsA/nfsB mutants</title>
                <p>The relative fitness of the mutants was determined by maximum bacterial growth rate in terms of doubling time, with an assumed increase in fitness corresponding to shorter doubling times. In the absence of nitrofurantoin (0 mg/L), there was no significant difference in doubling time between any of the mutants and their corresponding parental isolates (ANOVA 1646 BASE: <italic toggle="yes">P</italic> = 0.22; W3110: <italic toggle="yes">P</italic> = 0.46) (Tables <xref rid="dkac398-T1" ref-type="table">1</xref> and <xref rid="dkac398-T2" ref-type="table">2</xref>). Pairwise <italic toggle="yes">t</italic>-test analysis using a Bonferroni corrected significance threshold of <italic toggle="yes">P</italic> = 0.0009 agreed with the ANOVA analysis (Tables <xref rid="sup1" ref-type="supplementary-material">S3 and S4</xref>). These data are consistent with the initial growth analysis of 1646 and 2015 isolates (Figure <xref rid="dkac398-F2" ref-type="fig">2</xref>)</p>
                <table-wrap position="float" id="dkac398-T1">
                  <label>Table 1.</label>
                  <caption>
                    <p>Doubling times of mutants and clinical isolates relating to PAT1646 with or without nitrofurantoin</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col valign="top" align="left" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="left" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="left" rowspan="2" colspan="1">Strains</th>
                        <th align="center" colspan="8" rowspan="1">Nitrofurantoin concentration (mg/L)<sup><xref rid="dkac398-tblfn1" ref-type="table-fn">a</xref>,<xref rid="dkac398-tblfn2" ref-type="table-fn">b</xref></sup></th>
                      </tr>
                      <tr>
                        <th align="center" rowspan="1" colspan="1">0</th>
                        <th align="center" rowspan="1" colspan="1">2</th>
                        <th align="center" rowspan="1" colspan="1">4</th>
                        <th align="center" rowspan="1" colspan="1">8</th>
                        <th align="center" rowspan="1" colspan="1">16</th>
                        <th align="center" rowspan="1" colspan="1">32</th>
                        <th align="center" rowspan="1" colspan="1">64</th>
                        <th align="center" rowspan="1" colspan="1">128</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">1646 BASE</td>
                        <td rowspan="1" colspan="1">21.9 ± 0.9</td>
                        <td rowspan="1" colspan="1">24.7 ± 0.7</td>
                        <td rowspan="1" colspan="1">29.3 ± 1.1</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">43.2 </italic></bold>±<bold><italic toggle="yes"> 1.8</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">1646 6</td>
                        <td rowspan="1" colspan="1">25.7 ± 1.1</td>
                        <td rowspan="1" colspan="1">25.1 ± 0.6</td>
                        <td rowspan="1" colspan="1">24.5 ± 1.2</td>
                        <td rowspan="1" colspan="1">25.3 ± 1.1</td>
                        <td rowspan="1" colspan="1">27.9 ± 0.9</td>
                        <td rowspan="1" colspan="1">35.2 ± 1</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">142 </italic></bold>±<bold><italic toggle="yes"> 11.3</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">1646B Δ<italic toggle="yes">nfsA</italic></td>
                        <td rowspan="1" colspan="1">24.2 ± 0.6</td>
                        <td rowspan="1" colspan="1">24.3 ± 0.9</td>
                        <td rowspan="1" colspan="1">23.6 ± 1</td>
                        <td rowspan="1" colspan="1">31 ± 2</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">60.1 </italic></bold>±<bold><italic toggle="yes"> 1.6</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">1646B Δ<italic toggle="yes">nfsA-rimK</italic></td>
                        <td rowspan="1" colspan="1">23.7 ± 0.9</td>
                        <td rowspan="1" colspan="1">26.2 ± 1</td>
                        <td rowspan="1" colspan="1">25.4 ± 1.3</td>
                        <td rowspan="1" colspan="1">32.2 ± 1.9</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">64.7 </italic></bold>±<bold><italic toggle="yes"> 2.4</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">1646B <italic toggle="yes">nfsA</italic> T37M</td>
                        <td rowspan="1" colspan="1">22.5 ± 0.8</td>
                        <td rowspan="1" colspan="1">24.2 ± 0.9</td>
                        <td rowspan="1" colspan="1">24.1 ± 1</td>
                        <td rowspan="1" colspan="1">30.3 ± 2.1</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">55.4 </italic></bold>±<bold><italic toggle="yes"> 2.2</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">1646B Δ<italic toggle="yes">rimK</italic></td>
                        <td rowspan="1" colspan="1">24.1 ± 1.2</td>
                        <td rowspan="1" colspan="1">25.3 ± 0.4</td>
                        <td rowspan="1" colspan="1">28.3 ± 1.3</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">45.9 </italic></bold>±<bold><italic toggle="yes"> 1.4</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">1646B Δ<italic toggle="yes">nfsB</italic></td>
                        <td rowspan="1" colspan="1">22.2 ± 1.1</td>
                        <td rowspan="1" colspan="1">25.9 ± 0.8</td>
                        <td rowspan="1" colspan="1">29.6 ± 1</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">45 </italic></bold>±<bold><italic toggle="yes"> 0.9</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">1646B Δ<italic toggle="yes">rimK</italic> Δ<italic toggle="yes">nfsB</italic></td>
                        <td rowspan="1" colspan="1">21.8 ± 1.8</td>
                        <td rowspan="1" colspan="1">25.3 ± 1.2</td>
                        <td rowspan="1" colspan="1">30.5 ± 0.8</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">43.7 </italic></bold>±<bold><italic toggle="yes"> 1.6</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">1646B Δ<italic toggle="yes">nfsA</italic> Δ<italic toggle="yes">nfsB</italic></td>
                        <td rowspan="1" colspan="1">25.7 ± 0.4</td>
                        <td rowspan="1" colspan="1">25.6 ± 0.9</td>
                        <td rowspan="1" colspan="1">25 ± 0.5</td>
                        <td rowspan="1" colspan="1">24.3 ± 1</td>
                        <td rowspan="1" colspan="1">26.6 ± 0.3</td>
                        <td rowspan="1" colspan="1">34.2 ± 1.3</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">90.5 </italic></bold>±<bold><italic toggle="yes"> 5.9</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">1646B Δ<italic toggle="yes">nfsA</italic>-<italic toggle="yes">rimK</italic> Δ<italic toggle="yes">nfsB</italic></td>
                        <td rowspan="1" colspan="1">21.9 ± 1.6</td>
                        <td rowspan="1" colspan="1">23.4 ± 0.8</td>
                        <td rowspan="1" colspan="1">22.6 ± 0.7</td>
                        <td rowspan="1" colspan="1">23.4 ± 1.3</td>
                        <td rowspan="1" colspan="1">27.7 ± 0.9</td>
                        <td rowspan="1" colspan="1">33.7 ± 0.8</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">88 </italic></bold>±<bold><italic toggle="yes"> 3.4</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">1646B <italic toggle="yes">nfsA</italic> T37M Δ<italic toggle="yes">nfsB</italic></td>
                        <td rowspan="1" colspan="1">24.2 ± 0.8</td>
                        <td rowspan="1" colspan="1">25 ± 1.1</td>
                        <td rowspan="1" colspan="1">24.7 ± 0.5</td>
                        <td rowspan="1" colspan="1">27.7 ± 1</td>
                        <td rowspan="1" colspan="1">28.7 ± 0.5</td>
                        <td rowspan="1" colspan="1">37.6 ± 0.9</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">131.6 </italic></bold>±<bold><italic toggle="yes"> 10.8</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="dkac398-tblfn1">
                      <p>Italics and bold identify significant changes in the doubling time (Table <xref rid="sup1" ref-type="supplementary-material">S3</xref>).</p>
                    </fn>
                    <fn id="dkac398-tblfn2">
                      <p>Data relate to growth, while the MIC is defined as the first concentration having an OD<sub>600</sub> &lt; 0.05.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <table-wrap position="float" id="dkac398-T2">
                  <label>Table 2.</label>
                  <caption>
                    <p>Doubling times of mutants and the parental strain W3110 with or without nitrofurantoin</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col valign="top" align="left" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="left" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="left" rowspan="2" colspan="1">Strains</th>
                        <th align="center" colspan="8" rowspan="1">Nitrofurantoin concentration (mg/L)<sup><xref rid="dkac398-tblfn3" ref-type="table-fn">a</xref>,<xref rid="dkac398-tblfn4" ref-type="table-fn">b</xref></sup></th>
                      </tr>
                      <tr>
                        <th align="center" rowspan="1" colspan="1">0</th>
                        <th align="center" rowspan="1" colspan="1">2</th>
                        <th align="center" rowspan="1" colspan="1">4</th>
                        <th align="center" rowspan="1" colspan="1">8</th>
                        <th align="center" rowspan="1" colspan="1">16</th>
                        <th align="center" rowspan="1" colspan="1">32</th>
                        <th align="center" rowspan="1" colspan="1">64</th>
                        <th align="center" rowspan="1" colspan="1">128</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">W3110</td>
                        <td rowspan="1" colspan="1">34.9 ± 0.8</td>
                        <td rowspan="1" colspan="1">37.8 ± 1</td>
                        <td rowspan="1" colspan="1">37.7 ± 1.2</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">74.7 </italic></bold>±<bold><italic toggle="yes"> 2.9</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">W3110 Δ<italic toggle="yes">nfsA</italic></td>
                        <td rowspan="1" colspan="1">32.7 ± 1.7</td>
                        <td rowspan="1" colspan="1">35.4 ± 1.2</td>
                        <td rowspan="1" colspan="1">37.5 ± 1.8</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">50.9 </italic></bold>±<bold><italic toggle="yes"> 2.6</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">W3110 Δ<italic toggle="yes">nfsA-rimK</italic></td>
                        <td rowspan="1" colspan="1">33.1 ± 1.3</td>
                        <td rowspan="1" colspan="1">35.3 ± 1.1</td>
                        <td rowspan="1" colspan="1">40.4 ± 1.6</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">50.4 </italic></bold>±<bold><italic toggle="yes"> 2.1</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">W3110 <italic toggle="yes">nfsA</italic> T37M</td>
                        <td rowspan="1" colspan="1">29 ± 2.3</td>
                        <td rowspan="1" colspan="1">35.8 ± 1.1</td>
                        <td rowspan="1" colspan="1">38.8 ± 1.3</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">51.9 </italic></bold>±<bold><italic toggle="yes"> 2.4</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">W3110 Δ<italic toggle="yes">rimK</italic></td>
                        <td rowspan="1" colspan="1">33.8 ± 1.2</td>
                        <td rowspan="1" colspan="1">40.3 ± 1.9</td>
                        <td rowspan="1" colspan="1">44.4 ± 2</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">79.5 </italic></bold>±<bold><italic toggle="yes"> 5.6</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">W3110 Δ<italic toggle="yes">nfsB</italic></td>
                        <td rowspan="1" colspan="1">31.5 ± 3.1</td>
                        <td rowspan="1" colspan="1">34.9 ± 1.7</td>
                        <td rowspan="1" colspan="1">41.5 ± 1.4</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">73.7 </italic></bold>±<bold><italic toggle="yes"> 3.2</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">W3110 Δ<italic toggle="yes">rimK</italic> Δ<italic toggle="yes">nfsB</italic></td>
                        <td rowspan="1" colspan="1">35.8 ± 2.1</td>
                        <td rowspan="1" colspan="1">37.3 ± 1.4</td>
                        <td rowspan="1" colspan="1">39.9 ± 2.1</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">72 </italic></bold>±<bold><italic toggle="yes"> 4.3</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">W3110 Δ<italic toggle="yes">nfsA</italic> Δ<italic toggle="yes">nfsB</italic></td>
                        <td rowspan="1" colspan="1">31 ± 1.8</td>
                        <td rowspan="1" colspan="1">33.9 ± 0.8</td>
                        <td rowspan="1" colspan="1">36 ± 2.1</td>
                        <td rowspan="1" colspan="1">44.6 ± 1.6</td>
                        <td rowspan="1" colspan="1">39 ± 2.7</td>
                        <td rowspan="1" colspan="1">54.4 ± 1.9</td>
                        <td rowspan="1" colspan="1">
                          <bold>
                            <italic toggle="yes">117.2 ± 5.8</italic>
                          </bold>
                        </td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">W3110 Δ<italic toggle="yes">nfsA</italic>-<italic toggle="yes">rimK</italic> Δ<italic toggle="yes">nfsB</italic></td>
                        <td rowspan="1" colspan="1">32.5 ± 1</td>
                        <td rowspan="1" colspan="1">33.4 ± 0.9</td>
                        <td rowspan="1" colspan="1">34 ± 2</td>
                        <td rowspan="1" colspan="1">37.4 ± 1.6</td>
                        <td rowspan="1" colspan="1">32.8 ± 2.1</td>
                        <td rowspan="1" colspan="1">50.8 ± 1.4</td>
                        <td rowspan="1" colspan="1">
                          <bold>
                            <italic toggle="yes">97 ± 7.7</italic>
                          </bold>
                        </td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">W3110 <italic toggle="yes">nfsA</italic> T37M Δ<italic toggle="yes">nfsB</italic></td>
                        <td rowspan="1" colspan="1">34.4 ± 0.5</td>
                        <td rowspan="1" colspan="1">37.7 ± 1.3</td>
                        <td rowspan="1" colspan="1">38.2 ± 2</td>
                        <td rowspan="1" colspan="1">44.1 ± 0.8</td>
                        <td rowspan="1" colspan="1">40.3 ± 1.3</td>
                        <td rowspan="1" colspan="1"><bold><italic toggle="yes">56.7 </italic></bold>±<bold><italic toggle="yes"> 1.5</italic></bold></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="dkac398-tblfn3">
                      <p>Italics and bold identify significant changes in the doubling time (Table <xref rid="sup1" ref-type="supplementary-material">S4</xref>).</p>
                    </fn>
                    <fn id="dkac398-tblfn4">
                      <p>Data relate to growth, while the MIC is defined as the first concentration having an OD<sub>600</sub> &lt; 0.05.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>ANOVA analysis indicated that at 4 and 8 mg/L nitrofurantoin, there was significance within the bacterial growth data sets (<italic toggle="yes">P</italic>-value range &lt;0.0001–0.02) (Tables <xref rid="dkac398-T1" ref-type="table">1</xref> and <xref rid="dkac398-T2" ref-type="table">2</xref>) with pairwise comparisons using <italic toggle="yes">t</italic>-tests identifying specific trends. For example, at 4 mg/L nitrofurantoin an increase in doubling time from 21.9 ± 0.9 to 29.3 ± 1.1 min was observed for the parental strain 1646 BASE with comparable increases for <italic toggle="yes">nfsB</italic> and <italic toggle="yes">rimK</italic> single mutants (Table <xref rid="dkac398-T1" ref-type="table">1</xref>). This increase became statistically significant across all comparisons at 8 mg/L where a doubling time of 43–46 min was observed (Table <xref rid="dkac398-T1" ref-type="table">1</xref>: italics + bold and Table <xref rid="sup1" ref-type="supplementary-material">S3</xref>). The same trend was observed for W3110, which already had a lower intrinsic resistance to nitrofurantoin (Table <xref rid="dkac398-T2" ref-type="table">2</xref> and Table <xref rid="sup1" ref-type="supplementary-material">S4</xref>). At concentrations &gt;8 mg/L, most of these strains were unable to grow indicating that bacterial selection, rather than fitness, was the driving factor.</p>
                <p>Similar data for the Δ<italic toggle="yes">nfsA</italic>, double mutants and the control strain 1646 6 was observed at higher concentrations of nitrofurantoin (Table <xref rid="dkac398-T1" ref-type="table">1</xref>). Interestingly, the higher the concentration of antibiotic, the stronger the impact on growth with, for example, 64 mg/L leading to a 5-fold increase in doubling time for 1646 6. The 1646 BASE Δ<italic toggle="yes">nfsA</italic> Δ<italic toggle="yes">nfsB</italic> variant exhibited a 3.5-fold increase in doubling time at this concentration, consistent with the difference defined by the MIC analysis.</p>
              </sec>
              <sec id="dkac398-s2.6">
                <title>Viability of nfsA/nfsB mutants</title>
                <p>Growth experiments were initiated with an inoculation of between 0.01–0.05 OD<sub>600</sub>. This inoculum is equivalent to ∼1–5<bold> </bold>×<bold> </bold>10<sup>6</sup> cfu/mL, 1 log greater than the diagnostic threshold of microbes detected per millilitre of urine in an acute UTI (1 × 10<sup>5</sup> cfu/mL).<sup><xref rid="dkac398-B23" ref-type="bibr">23</xref></sup> It is well recognized that growth experiments can be influenced by the inoculum effect.<sup><xref rid="dkac398-B24" ref-type="bibr">24</xref></sup> Therefore, further growth analysis using a starting inoculum of 50–100 cfu/mL in 0 to 16 mg/L nitrofurantoin was investigated focussing on the viability of the 1646 BASE engineered strains rather than growth kinetics.</p>
                <p>All strains tested grew well with or without 2 mg/L nitrofurantoin (Table <xref rid="dkac398-T3" ref-type="table">3</xref>). The 1646 BASE strain did not grow at 4 mg/L while the Δ<italic toggle="yes">nfsB</italic> mutant showed a significant (∼6 log-fold) reduction in viability (Table <xref rid="dkac398-T3" ref-type="table">3</xref>). Furthermore, single mutants of Δ<italic toggle="yes">nfsA</italic> and <italic toggle="yes">nfsA</italic> T37M behaved in a similar manner, but at double the antibiotic concentration i.e. 8 mg/L. All strains that possessed a Nit<sup>R</sup> phenotype grew well at all nitrofurantoin concentrations tested. These data strengthen the argument for selective advantage over fitness for step-wise <italic toggle="yes">nfsA</italic><sup>−</sup> intermediates.</p>
                <table-wrap position="float" id="dkac398-T3">
                  <label>Table 3.</label>
                  <caption>
                    <p>Viability of test strains in low inoculum growth experiments with sub-MIC concentrations of nitrofurantoin</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col valign="top" align="left" span="1"/>
                      <col valign="top" align="left" span="1"/>
                      <col valign="top" align="left" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                      <col valign="top" align="center" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="left" rowspan="2" colspan="1">Strains</th>
                        <th align="center" colspan="5" rowspan="1">Nitrofurantoin concentration (mg/L)</th>
                      </tr>
                      <tr>
                        <th align="center" rowspan="1" colspan="1">0</th>
                        <th align="center" rowspan="1" colspan="1">2</th>
                        <th align="center" rowspan="1" colspan="1">4</th>
                        <th align="center" rowspan="1" colspan="1">8</th>
                        <th align="center" rowspan="1" colspan="1">16</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">1646 BASE</td>
                        <td rowspan="1" colspan="1">1.05E + 09</td>
                        <td rowspan="1" colspan="1">1.50E + 08</td>
                        <td rowspan="1" colspan="1">0</td>
                        <td rowspan="1" colspan="1">0</td>
                        <td rowspan="1" colspan="1">0</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">1646 6</td>
                        <td rowspan="1" colspan="1">6.67E + 08</td>
                        <td rowspan="1" colspan="1">4.03E + 08</td>
                        <td rowspan="1" colspan="1">4.63E + 08</td>
                        <td rowspan="1" colspan="1">2.88E + 08</td>
                        <td rowspan="1" colspan="1">1.56E + 08</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <italic toggle="yes">ΔnfsA</italic>
                        </td>
                        <td rowspan="1" colspan="1">8.37E + 08</td>
                        <td rowspan="1" colspan="1">1.83E + 08</td>
                        <td rowspan="1" colspan="1">3.13E + 08</td>
                        <td rowspan="1" colspan="1">1083</td>
                        <td rowspan="1" colspan="1">0</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"><italic toggle="yes">nfsA</italic> T37M</td>
                        <td rowspan="1" colspan="1">7.20E + 08</td>
                        <td rowspan="1" colspan="1">5.13E + 08</td>
                        <td rowspan="1" colspan="1">4.36E + 08</td>
                        <td rowspan="1" colspan="1">737</td>
                        <td rowspan="1" colspan="1">0</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <italic toggle="yes">ΔnfsB</italic>
                        </td>
                        <td rowspan="1" colspan="1">1.22E + 09</td>
                        <td rowspan="1" colspan="1">3.87E + 08</td>
                        <td rowspan="1" colspan="1">627</td>
                        <td rowspan="1" colspan="1">0</td>
                        <td rowspan="1" colspan="1">0</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <italic toggle="yes">ΔnfsA ΔnfsB</italic>
                        </td>
                        <td rowspan="1" colspan="1">5.47E + 08</td>
                        <td rowspan="1" colspan="1">2.80E + 08</td>
                        <td rowspan="1" colspan="1">2.53E + 08</td>
                        <td rowspan="1" colspan="1">2.62E + 08</td>
                        <td rowspan="1" colspan="1">9.67E + 07</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"><italic toggle="yes">nfsA</italic> T37M <italic toggle="yes">ΔnfsB</italic></td>
                        <td rowspan="1" colspan="1">6.80E + 08</td>
                        <td rowspan="1" colspan="1">2.73E + 08</td>
                        <td rowspan="1" colspan="1">4.50E + 08</td>
                        <td rowspan="1" colspan="1">2.96E + 08</td>
                        <td rowspan="1" colspan="1">1.63E + 08</td>
                      </tr>
                    </tbody>
                  </table>
                </table-wrap>
              </sec>
            </sec>
            <sec sec-type="discussion" id="dkac398-s3">
              <title>Discussion</title>
              <p>High level nitrofurantoin resistance requires the inactivation of two genes, which are located so far apart from each other (287 kb distance) that the likelihood of both being simultaneously inactivated through a single natural genetic event is non-existent.<sup><xref rid="dkac398-B9" ref-type="bibr">9</xref></sup> Hence inactivation of these genes is far more likely to occur in a step-wise manner, starting with <italic toggle="yes">nfsA</italic> followed by <italic toggle="yes">nfsB</italic>.</p>
              <p>To explore the evolutionary mechanism(s) underpinning antibiotic resistance Nit<sup>S</sup> and Nit<sup>R</sup> uro-associated <italic toggle="yes">E. coli</italic> isolates recovered from UTIs patients treated with nitrofurantoin were exploited. These strains were unique as they reflected <italic toggle="yes">in situ</italic> evolution of <italic toggle="yes">E. coli</italic> over 6 to 12 months in a clinical environment from Nit<sup>S</sup><italic toggle="yes">nfsAB</italic><sup>+</sup> (PAT1646) or <italic toggle="yes">nfsA</italic><sup>−</sup><italic toggle="yes">nfsB</italic><sup>+</sup> (PAT2015) genotypes to resistant genotypes.<sup><xref rid="dkac398-B12" ref-type="bibr">12</xref>,<xref rid="dkac398-B13" ref-type="bibr">13</xref></sup> Consistent with the literature, the predominant mutations leading to Nit<sup>R</sup> were deletions, although 1646 BASE to 1646 6 evolved Nit<sup>R</sup> via the acquisition of a point mutation in <italic toggle="yes">nfsA</italic>: T37M. MIC and growth data provided strong evidence that T37M significantly reduced or inactivated NfsA. However, the behaviour of <italic toggle="yes">nfsA</italic> T37M <italic toggle="yes">ΔnfsB</italic> variants with respect to growth in sub-MIC conditions argues a low level of activity may be retained (Tables <xref rid="dkac398-T1" ref-type="table">1</xref> and <xref rid="dkac398-T2" ref-type="table">2</xref>). Data also suggested that the method by which <italic toggle="yes">nfs</italic> genes were inactivated (Δ<italic toggle="yes">nfsA</italic>, <italic toggle="yes">nfsA</italic>T37M, Δ<italic toggle="yes">nfsB</italic>, Δ<italic toggle="yes">nfsB</italic>30) did not alter nitrofurantoin resistance with ≥64 mg/L MIC being observed for all combinations. Essentially, gene inactivation <italic toggle="yes">per se</italic> was more important than the mode of inactivation.</p>
              <p>Sandegren <italic toggle="yes">et al.</italic> argued that fitness of Nit<sup>R</sup> strains plays a key role in driving the low incidence of community AMR to nitrofurantoin.<sup><xref rid="dkac398-B11" ref-type="bibr">11</xref></sup> While the bacterial growth data reported in this study were consistent with Sandegren <italic toggle="yes">et al.</italic>, in that a small change in doubling times (2%–10%) was observed, statistical analysis (ANOVA and pairwise <italic toggle="yes">t</italic>-tests) argued that these growth changes were not significant and, alone, could not explain AMR. Moreover, growth analysis relating to 1646 BASE and W3110 strains and their genetic variants in the presence of sub-MIC Nitrofurantoin concentration supports our conclusion against fitness playing a major role in Nit<sup>R</sup> acquisition rates (Tables <xref rid="dkac398-T1" ref-type="table">1</xref> and <xref rid="dkac398-T2" ref-type="table">2</xref>). Bacterial resistance has traditionally been linked to the ability of isolates to grow in antibiotic concentrations that exceed the MIC of sensitive isolates. However, several studies have isolated resistant mutants from growth conditions where antibiotic concentrations were low enough for the proliferation of sensitive isolates.<sup><xref rid="dkac398-B25" ref-type="bibr">25–27</xref></sup></p>
              <p>Sub-MIC selective pressure may be a key factor in driving antibiotic resistant phenotypes to successfully establish themselves within a population. However, selective pressures will be determined not only by the pharmacodynamics of an antibiotic, but also by the genetic background of a bacterial species/strain. Findings reported here suggest that the nitrofurantoin selective window in relation to UTIs and uro-associated <italic toggle="yes">E. coli</italic> Nit<sup>R</sup>, is wide (&gt;8 mg/L), but this argument is only applicable when comparing Nit<sup>R</sup> double mutants against their Nit<sup>S</sup> parental isolates. From an evolutionary perspective, this comparison is biased as data suggests the emergence of Nit<sup>R</sup> mutants is highly dependent on the ability of intermediate mutants with low level nitrofurantoin resistance to establish themselves within a population of sensitive isolates. In fact, comparing the growth of mutants (Δ<italic toggle="yes">nfsA</italic>, <italic toggle="yes">nfsA</italic> T37M) modelling these intermediate scenarios to their parental isolates (1646 BASE and W3110), argues for a very narrow selective window (4–8 mg/L). Despite these strong selective pressures favouring growth, bacteria may still fail to establish themselves in the urinary environment due to bladder voiding.<sup><xref rid="dkac398-B28" ref-type="bibr">28</xref></sup></p>
              <p>Clinically, urinary nitrofurantoin concentrations rarely fall to within this narrow concentration range, which limits the selection of <italic toggle="yes">nfsA</italic> mutants.<sup><xref rid="dkac398-B29" ref-type="bibr">29</xref></sup> For example, extrapolating the urinary nitrofurantoin concentration data from Huttner <italic toggle="yes">et al.</italic> suggests the average urine concentration following a standard 50-mg dose may fluctuate between 20 and 40 mg/L during an 8-hour period.<sup><xref rid="dkac398-B29" ref-type="bibr">29</xref></sup> Essentially, these conditions inhibit intermediate mutants such as Δ<italic toggle="yes">nfsA</italic> and <italic toggle="yes">nfsA</italic> T37M establishing clinically, which in turn suppresses the emergence of double and hence Nit<sup>R</sup> mutants. Therefore, the rarity of Nit<sup>R</sup> intermediate mutants undermines the emergence of nitrofurantoin resistance in <italic toggle="yes">E. coli</italic>, explaining the low incidence of resistance.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material id="sup1" position="float" content-type="local-data">
                <label>dkac398_Supplementary_Data</label>
                <media xlink:href="dkac398_supplementary_data.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="ack1">
              <title>Acknowledgements</title>
              <p>The authors would like to thank all participants of the original AnTIC trial who agreed to their samples being banked for further analyses.</p>
            </ack>
            <sec id="dkac398-s4">
              <title>Funding</title>
              <p>The AnTIC trial was funded by NIHR HTA (no. 11/72/01). Direct funding for this project has included support for M.V. through European Association of Urology and Association Française D’Urologie Funding; EAU (Ref. ESUP/Scholarship S-02-2018) and AFU (Ref. Bourse AFU 2017). A.T. was a self-funded PhD thesis aided by a Newcastle University Overseas Research Scholarship. C.H. reiceves funding outside the scope of this work from UK National Institute of Health Research and The Urology Foundation.</p>
            </sec>
            <sec id="dkac398-s5">
              <title>Transparency declaration</title>
              <p>A.T., J.H. and P.D.A have no conflicts of interest to declare. M.V. has acted as a consultant for GSK outside the focus of this work, has received speakers fees from Astellas, IPSEN, Mylan and is on an Advisory board for IBSA PHARMA. C. H. has received speakers fees from Astellas, Allergan and Medtronic and is on Advisory boards for Astellas, Teleflex Medical, GSK, Viatris and Convatec. C.H. is also a member of the European Association of urology Female LUTS committee (chair) and the ICS Urodynamic, Mesh complications and Male LUTS committee.</p>
            </sec>
            <sec id="dkac398-s6">
              <title>Supplementary data</title>
              <p>Figures <xref rid="sup1" ref-type="supplementary-material">S1 and S2</xref> and Tables <xref rid="sup1" ref-type="supplementary-material">S1 to S4</xref> are available as <xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> at <italic toggle="yes">JAC</italic> online.</p>
            </sec>
            <ref-list id="ref1">
              <title>References</title>
              <ref id="dkac398-B1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huttner</surname><given-names>A</given-names></string-name>, <string-name><surname>Verhaegh</surname><given-names>EM</given-names></string-name>, <string-name><surname>Harbarth</surname><given-names>S</given-names></string-name><etal>et al</etal></person-group><article-title>Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials</article-title>. <source>J Antimicrob Chemother</source><year>2015</year>; <volume>70</volume>: <fpage>2456</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkv147</pub-id><pub-id pub-id-type="pmid">26066581</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Muller</surname><given-names>AE</given-names></string-name>, <string-name><surname>Verhaegh</surname><given-names>EM</given-names></string-name>, <string-name><surname>Harbarth</surname><given-names>S</given-names></string-name><etal>et al</etal></person-group><article-title>Nitrofurantoin</article-title>’<article-title>s efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials</article-title>. <source>Clin Microbiol Infect</source><year>2017</year>; <volume>23</volume>: <fpage>355</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmi.2016.08.003</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B3">
                <label>3</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><collab>National Institute for Health and Care Excellence</collab></person-group>. <comment>NICE Guideline [NG109] Urinary tract infection (lower): antimicrobial prescribing 2018.</comment><ext-link xlink:href="https://www.nice.org.uk/guidance/ng109" ext-link-type="uri">https://www.nice.org.uk/guidance/ng109</ext-link>.</mixed-citation>
              </ref>
              <ref id="dkac398-B4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hammond</surname><given-names>A</given-names></string-name>, <string-name><surname>Stuijfzand</surname><given-names>B</given-names></string-name>, <string-name><surname>Avison</surname><given-names>MB</given-names></string-name><etal>et al</etal></person-group><article-title>Antimicrobial resistance associations with national primary care antibiotic stewardship policy: primary care-based, multilevel analytic study</article-title>. <source>PLoS ONE</source><year>2020</year>; <volume>15</volume>: <comment>e0232903</comment>.</mixed-citation>
              </ref>
              <ref id="dkac398-B5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McOsker</surname><given-names>CC</given-names></string-name>, <string-name><surname>Fitzpatrick</surname><given-names>PM</given-names></string-name></person-group>. <article-title>Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens</article-title>. <source>J Antimicrob Chemother</source><year>1994</year>; <volume>33</volume>(<issue>Suppl A</issue>): <fpage>23</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1093/jac/33.suppl_A.23</pub-id><pub-id pub-id-type="pmid">7928834</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Farfour</surname><given-names>E</given-names></string-name>, <string-name><surname>Dortet</surname><given-names>L</given-names></string-name>, <string-name><surname>Guillard</surname><given-names>T</given-names></string-name><etal>et al</etal></person-group><article-title>Antimicrobial resistance in Enterobacterales recovered from urinary tract infections in France</article-title>. <source>Pathogens</source><year>2022</year>; <volume>11</volume>: <fpage>356</fpage>. <pub-id pub-id-type="doi">10.3390/pathogens11030356</pub-id><pub-id pub-id-type="pmid">35335681</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McCalla</surname><given-names>DR</given-names></string-name>, <string-name><surname>Kaiser</surname><given-names>C</given-names></string-name>, <string-name><surname>Green</surname><given-names>MH</given-names></string-name></person-group>. <article-title>Genetics of nitrofurazone resistance in <italic toggle="yes">Escherichia coli</italic></article-title>. <source>J Bacteriol</source><year>1978</year>; <volume>133</volume>: <fpage>10</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1128/jb.133.1.10-16.1978</pub-id><pub-id pub-id-type="pmid">338576</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wan</surname><given-names>Y</given-names></string-name>, <string-name><surname>Mills</surname><given-names>E</given-names></string-name>, <string-name><surname>Leung</surname><given-names>RCY</given-names></string-name><etal>et al</etal></person-group><article-title>Alterations in chromosomal genes <italic toggle="yes">nfsA</italic>, <italic toggle="yes">nfsB</italic>, and <italic toggle="yes">ribE</italic> are associated with nitrofurantoin resistance in Escherichia coli from the United Kingdom</article-title>. <source>Microb Genom</source><year>2021</year>; <volume>7</volume>. <fpage>000702</fpage><pub-id pub-id-type="pmid">34860151</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Whiteway</surname><given-names>J</given-names></string-name>, <string-name><surname>Koziarz</surname><given-names>P</given-names></string-name>, <string-name><surname>Veall</surname><given-names>J</given-names></string-name><etal>et al</etal></person-group><article-title>Oxygen-insensitive nitroreductases: analysis of the roles of <italic toggle="yes">nfsA</italic> and <italic toggle="yes">nfsB</italic> in development of resistance to 5-nitrofuran derivatives in <italic toggle="yes">Escherichia coli</italic></article-title>. <source>J Bacteriol</source><year>1998</year>; <volume>180</volume>: <fpage>5529</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1128/JB.180.21.5529-5539.1998</pub-id><pub-id pub-id-type="pmid">9791100</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname><given-names>F</given-names></string-name><etal>et al</etal></person-group><article-title>Unravelling mechanisms of nitrofurantoin resistance and epidemiological characteristics among <italic toggle="yes">Escherichia coli</italic> clinical isolates</article-title>. <source>Int J Antimicrob Agents</source><year>2018</year>; <volume>52</volume>: <fpage>226</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2018.04.021</pub-id><pub-id pub-id-type="pmid">29753133</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sandegren</surname><given-names>L</given-names></string-name>, <string-name><surname>Lindqvist</surname><given-names>A</given-names></string-name>, <string-name><surname>Kahlmeter</surname><given-names>G</given-names></string-name><etal>et al</etal></person-group><article-title>Nitrofurantoin resistance mechanism and fitness cost in <italic toggle="yes">Escherichia coli</italic></article-title>. <source>J Antimicrob Chemother</source><year>2008</year>; <volume>62</volume>: <fpage>495</fpage>–<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkn222</pub-id><pub-id pub-id-type="pmid">18544599</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fisher</surname><given-names>H</given-names></string-name>, <string-name><surname>Oluboyede</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chadwick</surname><given-names>T</given-names></string-name><etal>et al</etal></person-group><article-title>Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial</article-title>. <source>Lancet Infect Dis</source><year>2018</year>; <volume>18</volume>: <fpage>957</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(18)30279-2</pub-id><pub-id pub-id-type="pmid">30037647</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mowbray</surname><given-names>C</given-names></string-name>, <string-name><surname>Tan</surname><given-names>A</given-names></string-name>, <string-name><surname>Vallée</surname><given-names>M</given-names></string-name><etal>et al</etal></person-group><article-title>Multidrug-resistant uro-associated <italic toggle="yes">Escherichia coli</italic> populations and recurrent urinary tract infections in patients performing clean intermittent self-catheterisation</article-title>. <source>European Urology Open Science</source><year>2022</year>; <volume>37</volume>: <fpage>90</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.euros.2021.12.015</pub-id><pub-id pub-id-type="pmid">35243393</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bonifield</surname><given-names>HR</given-names></string-name>, <string-name><surname>Hughes</surname><given-names>KT</given-names></string-name></person-group>. <article-title>Flagellar phase variation in <italic toggle="yes">Salmonella enterica</italic> is mediated by a posttranscriptional control mechanism</article-title>. <source>J Bacteriol</source><year>2003</year>; <volume>185</volume>: <fpage>3567</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1128/JB.185.12.3567-3574.2003</pub-id><pub-id pub-id-type="pmid">12775694</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname><given-names>B</given-names></string-name>, <string-name><surname>Duan</surname><given-names>C</given-names></string-name><etal>et al</etal></person-group><article-title>Multigene editing in the <italic toggle="yes">Escherichia coli</italic> genome via the CRISPR-Cas9 system</article-title>. <source>Appl Environ Microbiol</source><year>2015</year>; <volume>81</volume>: <fpage>2506</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">25636838</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Datsenko</surname><given-names>KA</given-names></string-name>, <string-name><surname>Wanner</surname><given-names>BL</given-names></string-name></person-group>. <article-title>One-step inactivation of chromosomal genes in <italic toggle="yes">Escherichia coli</italic> K-12 using PCR products</article-title>. <source>Proc Natl Acad Sci USA</source><year>2000</year>; <volume>97</volume>: <fpage>6640</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.120163297</pub-id><pub-id pub-id-type="pmid">10829079</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sim</surname><given-names>M</given-names></string-name>, <string-name><surname>Koirala</surname><given-names>S</given-names></string-name>, <string-name><surname>Picton</surname><given-names>D</given-names></string-name><etal>et al</etal></person-group><article-title>Growth rate control of flagellar assembly in <italic toggle="yes">Escherichia coli</italic> strain RP437</article-title>. <source>Sci Rep</source><year>2017</year>; <volume>7</volume>: <fpage>41189</fpage>. <pub-id pub-id-type="doi">10.1038/srep41189</pub-id><pub-id pub-id-type="pmid">28117390</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hall</surname><given-names>BG</given-names></string-name>, <string-name><surname>Acar</surname><given-names>H</given-names></string-name>, <string-name><surname>Nandipati</surname><given-names>A</given-names></string-name><etal>et al</etal></person-group><article-title>Growth rates made easy</article-title>. <source>Mol Biol Evol</source><year>2014</year>; <volume>31</volume>: <fpage>232</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/mst187</pub-id><pub-id pub-id-type="pmid">24170494</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hayashi</surname><given-names>K</given-names></string-name>, <string-name><surname>Morooka</surname><given-names>N</given-names></string-name>, <string-name><surname>Yamamoto</surname><given-names>Y</given-names></string-name><etal>et al</etal></person-group><article-title>Highly accurate genome sequences of <italic toggle="yes">Escherichia coli</italic> K-12 strains MG1655 and W3110</article-title>. <source>Mol Syst Biol</source><year>2006</year>; <volume>2</volume>: <comment>2006.0007</comment>. <pub-id pub-id-type="doi">10.1038/msb4100049</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>G</given-names></string-name>, <string-name><surname>Jin</surname><given-names>Z</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name><etal>et al</etal></person-group><article-title>Structure and function of <italic toggle="yes">Escherichia coli</italic> RimK, an ATP-grasp fold, L-glutamyl ligase enzyme</article-title>. <source>Proteins</source><year>2013</year>; <volume>81</volume>: <fpage>1847</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1002/prot.24311</pub-id><pub-id pub-id-type="pmid">23609986</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andrews</surname><given-names>JM</given-names></string-name></person-group>. <article-title>Determination of minimum inhibitory concentrations</article-title>. <source>J Antimicrob Chemother</source><year>2001</year>; <volume>48</volume>(<issue>Suppl 1</issue>):<fpage>5</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1093/jac/48.suppl_1.5</pub-id><pub-id pub-id-type="pmid">11420333</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rodloff</surname><given-names>A</given-names></string-name>, <string-name><surname>Bauer</surname><given-names>T</given-names></string-name>, <string-name><surname>Ewig</surname><given-names>S</given-names></string-name><etal>et al</etal></person-group><article-title>Susceptible, intermediate, and resistant—the intensity of antibiotic action</article-title>. <source>Dtsch Arztebl Int</source><year>2008</year>; <volume>105</volume>: <fpage>657</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">19626213</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Foxman</surname><given-names>B</given-names></string-name></person-group>. <article-title>Epidemiology of urinary tract infections: incidence, morbidity, and economic costs</article-title>. <source>Am J Med</source><year>2002</year>; <volume>113</volume>(<issue>Suppl 1A</issue>):<fpage>5S</fpage>–<lpage>13S</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9343(02)01054-9</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>KP</given-names></string-name>, <string-name><surname>Kirby</surname><given-names>JE</given-names></string-name></person-group>. <article-title>The inoculum effect in the era of multidrug resistance: minor differences in inoculum have dramatic effect on MIC determination</article-title>. <source>Antimicrob Agents Chemother</source><year>2018</year>; <volume>62</volume>: <comment>e000433–18</comment>.</mixed-citation>
              </ref>
              <ref id="dkac398-B25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andersson</surname><given-names>DI</given-names></string-name>, <string-name><surname>Hughes</surname><given-names>D</given-names></string-name></person-group>. <article-title>Microbiological effects of sublethal levels of antibiotics</article-title>. <source>Nature Reviews Microbiology</source><year>2014</year>; <volume>12</volume>: <fpage>465</fpage>–<lpage>478</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro3270</pub-id><pub-id pub-id-type="pmid">24861036</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hughes</surname><given-names>D</given-names></string-name>, <string-name><surname>Andersson</surname><given-names>DI</given-names></string-name></person-group>. <article-title>Selection of resistance at lethal and non-lethal antibiotic concentrations</article-title>. <source>Curr Opin Microbiol</source><year>2012</year>; <volume>15</volume>: <fpage>555</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2012.07.005</pub-id><pub-id pub-id-type="pmid">22878455</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andersson</surname><given-names>DI</given-names></string-name>, <string-name><surname>Hughes</surname><given-names>D</given-names></string-name></person-group>. <article-title>Evolution of antibiotic resistance at non-lethal drug concentrations</article-title>. <source>Drug Resist Updat</source><year>2012</year>; <volume>15</volume>: <fpage>162</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.drup.2012.03.005</pub-id><pub-id pub-id-type="pmid">22516308</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sintsova</surname><given-names>A</given-names></string-name>, <string-name><surname>Frick-Cheng</surname><given-names>AE</given-names></string-name>, <string-name><surname>Smith</surname><given-names>S</given-names></string-name><etal>et al</etal></person-group><article-title>Genetically diverse uropathogenic <italic toggle="yes">Escherichia coli</italic> adopt a common transcriptional program in patients with UTIs</article-title>. <source>Elife</source><year>2019</year>; <volume>8</volume>: <fpage>e49748</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.49748</pub-id><pub-id pub-id-type="pmid">31633483</pub-id></mixed-citation>
              </ref>
              <ref id="dkac398-B29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huttner</surname><given-names>A</given-names></string-name>, <string-name><surname>Wijma</surname><given-names>RA</given-names></string-name>, <string-name><surname>Stewardson</surname><given-names>AJ</given-names></string-name><etal>et al</etal></person-group><article-title>The pharmacokinetics of nitrofurantoin in healthy female volunteers: a randomized crossover study</article-title>. <source>J Antimicrob Chemother</source><year>2019</year>; <volume>74</volume>: <fpage>1656</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkz095</pub-id><pub-id pub-id-type="pmid">30859184</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
